EORTC-endorsed, Prospective European Multicenter Imaging Survey and Protocol
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Avelumab Plus Cetuximab in Pre-treated RAS Wild Type Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy for Resectable Colorectal Liver Metastases
- Status
- COMPLETED
- Phase
- N/A
MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate U3-1402 in Subjects With Advanced or Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)
- Status
- COMPLETED
- Phase
- PHASE3
Sequences Of REGorafenib And Trifluridine/Tipiracil in Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Expanded Access of Onvansertib With FOLFIRI and Bevacizumab for the Second-Line Treatment of Participants With KRAS-Mutated Metastatic Colorectal Cancer
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Immunotherapy for Third Line Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
FOLFOX + Immunotherapy With Intrahepatic Oxaliplatin for Patients With Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- N/A
Patients' Guidance With Onco-Coaching and CANKADO on Systemic Chemotherapy for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- N/A
A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2